What is personalized medicine, and how is it different from standard treatment

TL;DR: Personalized medicine uses YOUR specific cancer's genetic makeup and characteristics to choose treatments tailored to you, rather than giving everyone with the same cancer type the same drugs.

KEY POINTS:

• Standard treatment is a "one-size-fits-most" approach based on cancer type and stage; personalized medicine customizes treatment based on YOUR tumor's unique genetic mutations and biomarkers
• Genetic testing of your tumor (not your blood) identifies specific mutations that drive YOUR cancer, which helps doctors pick drugs that target those exact mutations
• Personalized medicine can mean better response rates, fewer side effects, and avoiding drugs that won't work for your specific cancer
• Not all cancers have personalized options yet, but this approach is becoming standard for many common cancers (breast, lung, colorectal, melanoma, blood cancers)
• Your oncologist decides which tests make sense for your cancer type and which personalized options apply to YOUR situation

NEXT STEP: Ask your oncologist: "Has my tumor been tested for genetic mutations or biomarkers? Are there personalized treatment options available for my specific cancer?"

---

FULL ANSWER

What Is Personalized Medicine?

Personalized medicine (also called precision medicine or precision oncology) is an approach where your cancer treatment is customized based on the specific genetic mutations and characteristics of YOUR tumor—not just your cancer type and stage.

Think of it this way: Two patients might both have "lung cancer," but their tumors could have completely different genetic mutations driving the cancer. Standard treatment might give both patients the same chemotherapy. Personalized medicine, instead, tests each tumor to find out what's actually making it grow, then picks drugs that target those specific mutations.

How Is It Different From Standard Treatment?

Standard Treatment (Traditional Approach):

• Based on cancer type, stage, and general patient factors (age, overall health)
• Same treatment protocol for most patients with the same diagnosis
• Example: All patients with stage 3 breast cancer get similar chemotherapy regimens
• Doctors choose drugs based on what has historically worked for that cancer type

Personalized Medicine (Precision Approach):

• Based on YOUR tumor's unique genetic profile
• Treatment customized to the specific mutations driving YOUR cancer
• Example: A breast cancer patient with HER2 overexpression gets trastuzumab (Herceptin); one with BRCA mutations might get PARP inhibitors; one with hormone receptor positivity gets endocrine therapy
• Doctors choose drugs based on what will work for YOUR specific tumor's mutations

The Clinical Reasoning Behind Personalized Medicine

According to NCCN (National Comprehensive Cancer Network) Guidelines, genetic and biomarker testing is now standard practice for many cancer types because:

1. Mutations drive cancer growth — Cancer cells have specific genetic changes that make them grow. If you can identify those changes, you can target them directly.

2. Different mutations respond to different drugs — A drug that works brilliantly for one mutation may not work at all for another. Testing tells you which drugs have the best chance of working.

3. Avoid ineffective treatments — If your tumor doesn't have a specific mutation, a drug targeting that mutation won't help you. Testing prevents wasted time and side effects from drugs that won't work.

4. Better outcomes — Targeted drugs often work better and cause fewer side effects than broad chemotherapy because they attack cancer cells more specifically.

What Tests Are Used?

Common personalized medicine tests include:

• Tumor genetic sequencing — Tests your tumor tissue (from biopsy or surgery) for mutations in cancer-related genes
• Biomarker testing — Looks for specific proteins or genetic changes (like HER2, PD-L1, BRCA mutations, microsatellite instability)
• Gene expression profiling — Measures which genes are "turned on" in your tumor to predict behavior and treatment response
• Liquid biopsy — Sometimes blood tests can detect circulating tumor DNA to monitor treatment response

Examples of Personalized Medicine in Action

Breast Cancer:

• ER/PR positive → Hormone therapy (tamoxifen, aromatase inhibitors)
• HER2 positive → HER2-targeted therapy (trastuzumab/Herceptin)
• Triple negative with BRCA mutation → PARP inhibitors (olaparib, rucaparib)

Lung Cancer:

• EGFR mutation → EGFR inhibitors (erlotinib, gefitinib)
• ALK rearrangement → ALK inhibitors (crizotinib, alectinib)
• PD-L1 high expression → Immunotherapy (pembrolizumab, nivolumab)

Melanoma:

• BRAF mutation → BRAF inhibitors (vemurafenib, dabrafenib)
• No BRAF mutation → Immunotherapy checkpoint inhibitors

Colorectal Cancer:

• KRAS wild-type → EGFR inhibitors (cetuximab, panitumumab)
• KRAS mutant → Different chemotherapy combinations
• Microsatellite instability (MSI-H) → Immunotherapy

Current State of Personalized Medicine

According to the American Cancer Society and ASCO (American Society of Clinical Oncology) guidelines:

• Widely available for: Breast cancer, lung cancer, colorectal cancer, melanoma, ovarian cancer, pancreatic cancer, and blood cancers
• Increasingly available for: Many other cancer types
• Still developing for: Some less common cancers

However, not every patient has personalized options available yet. Some cancers don't have identified targetable mutations, or the drugs targeting those mutations may not be approved or available. Your oncologist will determine which tests make sense for your specific cancer.

Important Distinctions

Personalized medicine is NOT:

• Genetic testing of YOUR blood (that's germline testing, which looks for inherited cancer risk)
• A guarantee of cure or specific outcome
• Available for every cancer type or every patient
• A replacement for standard treatment—sometimes standard chemotherapy is still the best option

Personalized medicine IS:

• Testing of YOUR TUMOR tissue to find mutations
• A way to match drugs to your specific cancer's biology
• Increasingly becoming standard care for many cancers
• Often combined with standard treatments for best results

Questions to Ask Your Oncologist

1. "Has my tumor been tested for genetic mutations or biomarkers?" (If not: "Should it be?")
2. "What specific mutations or biomarkers does my tumor have?"
3. "Are there targeted drugs available for my tumor's mutations?"
4. "What are the pros and cons of personalized treatment options versus standard treatment for my case?"
5. "Are there clinical trials testing personalized approaches for my cancer?"

Why This Matters for You

Personalized medicine can mean:

• Better response rates — Drugs targeting your specific mutations often work better than broad chemotherapy
• Fewer side effects — Targeted drugs are often gentler because they attack cancer cells more specifically
• Avoiding ineffective treatments — You won't waste time on drugs that won't work for your tumor
• More treatment options — Understanding your tumor's mutations opens doors to newer therapies and clinical trials

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.